Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Tax and related expenses | $ 0 | $ 18 |
| Restructuring related accrual | 12,598 | 0 |
| Other | 2,913 | 4,009 |
| Total accrued expenses and other current liabilities | 34,581 | 31,250 |
| Supply Agreement | Vaxcyte, Inc. | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Collaboration and license agreements and supply agreement accruals | 12,713 | 12,435 |
| CMO | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Collaboration and license agreements and supply agreement accruals | 5,853 | 8,525 |
| Clinical Trials | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Collaboration and license agreements and supply agreement accruals | $ 504 | $ 6,263 |